Basic Information
| LncRNA/CircRNA Name | LINC00882 |
| Synonyms | NA |
| Region | GRCh38_3:106836811-107240641 |
| Ensemble | ENSG00000242759 |
| Refseq | NR_028303 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot, other |
| Sample | HCC tissues and cell lines (HCCLM3 and Hep3B) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA 882 (LINC00882) is one of the lncRNAs that was significantly upregulated in HCC tissues compared with normal liver tissues. We verified the upregulation of LINC00882 in HCC by using two separate cohorts that contained 85 HCC tissues and paired adjacent noncancerous tissues and 86 HCC tissues and 89 independent noncancerous liver tissues, respectively. |
| Pubmed ID | 30271163 |
| Year | 2018 |
| Title | Overexpression of Long Noncoding RNA LINC00882 Is Associated With Poor Prognosis in Hepatocellular Carcinoma |
External Links
| Links for LINC00882 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |